The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL1178     6-methylsulfanyl-7H-purine

Synonyms: PU08, SureCN240979, SureCN240980, CCRIS 3910, AG-K-73524, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Thiopurine S-methylether


High impact information on Thiopurine S-methylether


Chemical compound and disease context of Thiopurine S-methylether


Biological context of Thiopurine S-methylether


Anatomical context of Thiopurine S-methylether


Associations of Thiopurine S-methylether with other chemical compounds


Gene context of Thiopurine S-methylether


Analytical, diagnostic and therapeutic context of Thiopurine S-methylether


  1. Potentiation by guanine nucleosides of the growth-inhibitory effects of adenosine analogs on L1210 and sarcoma 180 cells in culture. Grindey, G.B., Lowe, J.K., Divekar, A.Y., Hakala, M.T. Cancer Res. (1976) [Pubmed]
  2. Comparison of the effects of 6- thio- and 6-methylthiopurine ribonucleoside cyclic monophosphates withtheir corresponding nucleosides on the growth of rat hepatoma cells. Koontz, J.W., Wicks, W.D. Cancer Res. (1977) [Pubmed]
  3. New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation. Cottam, H.B., Wasson, D.B., Shih, H.C., Raychaudhuri, A., Di Pasquale, G., Carson, D.A. J. Med. Chem. (1993) [Pubmed]
  4. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine. Chrzanowska, M., Krzymański, M. Therapeutic drug monitoring. (1999) [Pubmed]
  5. Metabolites of mercaptopurine in red blood cells: a relationship between 6-thioguanine nucleotides and 6-methylmercaptopurine metabolite concentrations in children with lymphoblastic leukemia. Chrzanowska, M., Kolecki, P., Duczmal-Cichocka, B., Fiet, J. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. (1999) [Pubmed]
  6. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. Presta, M., Rusnati, M., Belleri, M., Morbidelli, L., Ziche, M., Ribatti, D. Cancer Res. (1999) [Pubmed]
  7. Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase. Hurley, M.C., Lin, B., Fox, I.H. J. Biol. Chem. (1985) [Pubmed]
  8. 6-Methylmercaptopurine riboside is a potent and selective inhibitor of nerve growth factor-activated protein kinase N. Volonté, C., Greene, L.A. J. Neurochem. (1992) [Pubmed]
  9. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. de Boer, N.K., Jarbandhan, S.V., de Graaf, P., Mulder, C.J., van Elburg, R.M., van Bodegraven, A.A. Am. J. Gastroenterol. (2006) [Pubmed]
  10. Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts. Stet, E.H., De Abreu, R.A., Bökkerink, J.P., Vogels-Mentink, T.M., Lambooy, L.H., Trijbels, F.J., Trueworthy, R.C. Biochem. Pharmacol. (1993) [Pubmed]
  11. Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease. Gilissen, L.P., Derijks, L.J., Verhoeven, H.M., Bierau, J., Hooymans, P.M., Hommes, D.W., Engels, L.G. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2007) [Pubmed]
  12. Crystal structures of azathioprine dihydrate and 6-methylmercaptopurine trihydrate. Cook, W.J., Bugg, C.E. Journal of pharmaceutical sciences. (1975) [Pubmed]
  13. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population. Kubota, T., Nishida, A., Takeuchi, K., Iida, T., Yokota, H., Higashi, K., Nakahara, K., Hanai, H., Iga, T. Therapeutic drug monitoring. (2004) [Pubmed]
  14. Relationship between phosphorylation and cytotoxicity of 2-chloroadenosine and 6-methylmercaptopurine riboside in human cells. Yamanaka, H., Kamatani, N., Nishida, Y., Nishioka, K., Mikanagi, K. Biochim. Biophys. Acta (1984) [Pubmed]
  15. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients. Gilissen, L.P., Bierau, J., Derijks, L.J., Bos, L.P., Hooymans, P.M., van Gennip, A., Stockbrügger, R.W., Engels, L.G. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  16. Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs. Cory, A.H., Cory, J.G. Adv. Enzyme Regul. (1994) [Pubmed]
  17. 6-Methylmercaptopurine riboside resistance in human lymphocytes in the in vivo somatic cell mutation test. Wong, Y.W., Tomkins, D.J. Environmental mutagenesis. (1986) [Pubmed]
  18. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Sparrow, M.P., Hande, S.A., Friedman, S., Lim, W.C., Reddy, S.I., Cao, D., Hanauer, S.B. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  19. Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo. Giverhaug, T., Fuskevaag, O.M., Aarbakke, J. Cancer Chemother. Pharmacol. (1997) [Pubmed]
  20. Reaction kinetics and inhibition of adenosine kinase from Leishmania donovani. Bhaumik, D., Datta, A.K. Mol. Biochem. Parasitol. (1988) [Pubmed]
  21. Status of methylthioadenosine phosphorylase and its impact on cellular response to L-alanosine and methylmercaptopurine riboside in human soft tissue sarcoma cells. Li, W., Su, D., Mizobuchi, H., Martin, D.S., Gu, B., Gorlick, R., Cole, P., Bertino, J.R. Oncol. Res. (2004) [Pubmed]
  22. Assay of 6-mercaptopurine and its metabolites in patient plasma by high-performance liquid chromatography with diode-array detection. Su, Y., Hon, Y.Y., Chu, Y., Van de Poll, M.E., Relling, M.V. J. Chromatogr. B Biomed. Sci. Appl. (1999) [Pubmed]
  23. ESR of sulfur-substituted purines. 6-methylmercaptopurine at 300 K. Pugh, H.L., Alexander, C. Radiat. Res. (1976) [Pubmed]
  24. Resistance to pyrazofurin and 6-azauridine in normal MC3T3-E1 murine osteoblasts. Beidler, D.R., Candia, A.F., Chernin, M.I., Novak, J.F. Biochim. Biophys. Acta (1989) [Pubmed]
  25. High 6-thioguanine nucleotide levels and low thiopurine methyltransferase activity in patients with lupus erythematosus treated with azathioprine. Decaux, G., Horsmans, Y., Houssiau, F., Desager, J.P. American journal of therapeutics. (2001) [Pubmed]
  26. Determination of thiopurine methyltransferase activity in human erythrocytes by high-performance liquid chromatography: comparison with the radiochemical method. Menor, C., Fueyo, J.A., Escribano, O., Cara, C., Fernández-Moreno, M.D., Román, I.D., Guijarro, L.G. Therapeutic drug monitoring. (2001) [Pubmed]
WikiGenes - Universities